LAVA THERAPEUTICS NV's ticker is LVTX and the CUSIP is N51517105. A total of 19 filers reported holding LAVA THERAPEUTICS NV in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $374,742 | -52.9% | 225,748 | -0.8% | 0.00% | -66.7% |
| Q4 2022 | $796,184 | -61.9% | 227,481 | -50.3% | 0.00% | -25.0% |
| Q3 2022 | $2,090,026 | +55.7% | 457,342 | +0.5% | 0.00% | +100.0% |
| Q2 2022 | $1,342,045 | -34.2% | 454,946 | -1.9% | 0.00% | -33.3% |
| Q1 2022 | $2,040,298 | +60.0% | 463,772 | +100.0% | 0.00% | 0.0% |
| Q4 2021 | $1,275,000 | -6.0% | 231,884 | +1.2% | 0.00% | -25.0% |
| Q3 2021 | $1,356,000 | -71.8% | 229,121 | -48.1% | 0.00% | -42.9% |
| Q2 2021 | $4,802,000 | +43.5% | 441,326 | +100.3% | 0.01% | -30.0% |
| Q1 2021 | $3,347,000 | – | 220,363 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 610,809 | $2,791,000 | 0.94% |
| Novo Holdings A/S | 3,327,312 | $15,206,000 | 0.72% |
| Redmile Group, LLC | 2,816,196 | $12,870,000 | 0.50% |
| Alpha Wave Global, LP | 121,193 | $554,000 | 0.06% |
| Artal Group S.A. | 200,000 | $914,000 | 0.04% |
| Cannell Capital | 17,955 | $82,000 | 0.02% |
| UBS OCONNOR LLC | 75,000 | $343,000,000 | 0.01% |
| AXA S.A. | 457,342 | $2,090,026 | 0.00% |
| TSFG, LLC | 400 | $2,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 48 | $0 | 0.00% |